Legal & General Group
FBRX icon

Legal & General Group’s Forte Biosciences FBRX Stock Holding History

Legal & General Group’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48
Closed -$2K – 3568
2022
Q1 		$2K Hold
48
– – ﹤0.01% 3548
2021
Q4 		$3K Hold
48
– – ﹤0.01% 3561
2021
Q3 		$4K Hold
48
– – ﹤0.01% 3483
2021
Q2 		$40K Buy
+48
New +$43.3K ﹤0.01% 3022
2020
Q2 		– Sell
-8
Closed -$4K – 3426
2020
Q1 		$4K Sell
8
-4
-33% -$1.56K ﹤0.01% 3283
2019
Q4 		$2K Buy
12
+2
+20% +$453 ﹤0.01% 3362
2019
Q3 		$2K Hold
10
– – ﹤0.01% 3344
2019
Q2 		$24K Hold
10
– – ﹤0.01% 3124
2019
Q1 		$40K Buy
10
+2
+25% +$7.73K ﹤0.01% 2789
2018
Q4 		$24K Hold
8
– – ﹤0.01% 3003
2018
Q3 		$45K Buy
8
+2
+33% +$7.61K ﹤0.01% 2824
2018
Q2 		$21K Sell
6
-2
-25% -$7.32K ﹤0.01% 3171
2018
Q1 		$37K Hold
8
– – ﹤0.01% 2891
2017
Q4 		$32K Buy
8
+5
+167% +$20K ﹤0.01% 3031
2017
Q3 		$16K Hold
3
– – ﹤0.01% 3214
2017
Q2 		$15K Buy
+3
New +$16.9K ﹤0.01% 3257

Other funds holding FBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Legal & General Group's FBRX Position: Q2 2022 in Review

Legal & General Group sold out of Forte Biosciences (FBRX) in Q2 2022, closing a stake of 48 shares — an estimated $2K sold.

Legal & General Group first reported a position in FBRX in Q2 2017 and held it in 16 quarters. The position peaked at $45K in Q3 2018. 39 funds tracked by Wall St. Rank hold FBRX as of Q2 2022.

  • Legal & General Group reported no remaining Forte Biosciences position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 48 Forte Biosciences shares in Q2 2022, an estimated $2K.
  • Legal & General Group first reported a position in Forte Biosciences in Q2 2017 and held it in 16 quarters.
  • Legal & General Group's Forte Biosciences position peaked at $45K in Q3 2018.
  • 39 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.